
Case Report Demonstrates Potential of CGRP-Targeting Medication to Treat Post-Subarachnoid Hemorrhage Headaches
A case report recently published in Headache showed that use of erenumab (Aimovig; Amgen), an FDA-approved calcitonin gene-related peptide (CGRP) treatment, was successful in improving persistent refractory headaches in a patient with aneurysmal …